Apogee Therapeutics Inc. (APGE)

Precedente Chiudi:

$52.22

Aprire:

$51.33

Volume 24 ore:

177.64K

Capitalizzazione di mercato:

$2.89B

Reddito:

-

Utile/perdita netta:

$-71.91M

Rapporto P/E:

-

EPS:

-

Flusso di cassa netto:

-

1 W Prestazione:

+0.69%

1M Prestazione:

-6.10%

6M Prestazione:

+216.42%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$49.57

$52.23

Portata 52W:

$14.19

$72.29

Apogee Therapeutics Inc. Stock (APGE) Company Profile

Nome

Apogee Therapeutics Inc.

Settore

Healthcare (1217)

Industria

Biotechnology (697)

Telefono

650-394-5230

Indirizzo

221 Crescent Street, Building 17 Suite 102b, Waltham

Dipendente

0

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

APGE's Discussions on Twitter

Apogee Therapeutics Inc. Stock (APGE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-20	Iniziato	BTIG Research	Buy
2023-08-08	Iniziato	Guggenheim	Buy
2023-08-08	Iniziato	Jefferies	Buy
2023-08-08	Iniziato	Stifel	Buy
2023-08-08	Iniziato	TD Cowen	Outperform
2023-08-08	Iniziato	Wedbush	Outperform

Mostra tutto

Apogee Therapeutics Inc. Borsa (APGE) Ultime notizie

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

GlobeNewswire Inc.

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Zacks Investment Research

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases

GlobeNewswire Inc.

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Benzinga

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

GlobeNewswire Inc.

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering

GlobeNewswire Inc.

Apogee Therapeutics Inc. Azioni (APGE) Dati Finanziari

Apogee Therapeutics Inc. (APGE) Reddito netto 2024

Apogee Therapeutics Inc. (APGE) Utile per azione 2024

Apogee Therapeutics Inc. Azioni (APGE) insider trading